Sartorius (OTCMKTS:SARTF) Shares Gap Down - Should You Sell?

Key Points

• Sartorius shares gapped down from a previous close of $200.20 to open at $184.27 on Friday, with very low trading volume.
• Analyst DZ Bank upgraded Sartorius from a "strong sell" to a "hold" rating on April 17th.
• The company's recent earnings report showed an EPS of $1.38, missing estimates by ($0.11), despite revenues of $1.04 billion surpassing expectations.
• Sartorius maintains a market capitalization of $6.31 billion with a P/E ratio of 112.36.

Sartorius (OTCMKTS:SARTF - Get Free Report) gapped down prior to trading on Friday . The stock had previously closed at $200.20, but opened at $184.27. Sartorius shares last traded at $184.27, with a volume of 1 shares trading hands.

Analyst Upgrades and Downgrades

Separately, DZ Bank raised shares of Sartorius from a "strong sell" rating to a "hold" rating in a research note on Thursday, April 17th.

Sartorius Price Performance

The company has a debt-to-equity ratio of 1.09, a current ratio of 1.46 and a quick ratio of 0.93. The company's 50 day moving average price is $200.07 and its 200 day moving average price is $200.41. The firm has a market capitalization of $6.31 billion, a P/E ratio of 112.36 and a beta of 1.07.

Sartorius (OTCMKTS:SARTF - Get Free Report) last released its quarterly earnings results on Tuesday, July 22nd. The company reported $1.38 EPS for the quarter, missing the consensus estimate of $1.49 by ($0.11). Sartorius had a net margin of 3.00% and a return on equity of 7.87%. The company had revenue of $1.04 billion for the quarter, compared to the consensus estimate of $977.90 million.

About Sartorius

Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services in the United States and internationally. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors, and software apps for bioreactors and cell culture shake flask; fermenters; cell culture media products; cellcelector flex, incubator flowbox, nanowell arrays, and capillaries and tips; fluid management products; microbiology products; and Ultrafiltration membrane filters, glass and quartz microfiber filters, clarification, syringeless and in-line filters, lab chromatography, and filters and blotting papers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.